Dana Larocca PhD

Dana Larocca is Vice President of Discovery Research at AgeX Therapeutics and Vice President of Research and Development at ReCyte Therapeutics. Prior to ReCyte, she founded Mandala Biosciences, LLC in 2008, where she served as Chief Executive Officer. At Mandala, she raised over $3M in non-dilutive funding from SBIR and CIRM grants and managed a team focused on developing targeted nanoparticle probes for identifying, tracking and manufacturing purified therapeutic stem cells. Dr. Larocca previously held joint positions at Advanced Cell Technology (now Astellas) and the Sanford Burnham Medical Research Institute. She is author of over 40 scientific publications and inventor of 23 patents and patent applications in the fields of immunotherapy, gene therapy, and regenerative medicine. Dr. Larocca holds a Ph.D. in Molecular and Cellular Biology from the University of Southern California and a B.S. in Biology from Ithaca College. She did her post-doctoral training at Harvard University.